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Conditioned Response Evoked by Nicotine Conditioned
Stimulus Preferentially Induces c-Fos Expression in
Medial Regions of Caudate-Putamen
Sergios Charntikov1,2, Matthew E Tracy1,3, Changjiu Zhao1,4, Ming Li1,2 and Rick A Bevins*,1,2
1

Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA

Nicotine has both unconditioned and conditioned stimulus properties. Conditioned stimulus properties of nicotine may contribute to the
tenacity of nicotine addiction. The purpose of this experiment was to use neurohistochemical analysis of rapidly developing c-Fos protein
to elucidate neurobiological loci involved in the processing of nicotine as an interoceptive conditioned stimulus (CS). Rats were injected
(SC) in an intermixed fashion with saline or nicotine (16 sessions of each) and placed in conditioning chambers where they were given
one of the three conditions depending on group assignment: (a) nicotine paired 100% of the time with intermittent access to sucrose
(nicotine-CS condition), (b) nicotine and saline each paired 50% of the time with sucrose (chamber-CS condition), or (c) no sucrose US
control (CS-alone condition). Rats in the nicotine-CS condition acquired the discrimination as evidenced by goal-tracking (ie, increased
dipper entries before initial sucrose delivery) only on nicotine sessions. The chamber-CS condition showed goal-tracking on all sessions;
no goal-tracking was seen in the CS-alone condition. On the test day, rats in each condition were challenged with saline or nicotine and
later assessed for c-Fos immunoreactivity. In concordance with previous reports, nicotine induced c-Fos expression in the majority of
areas tested; however, learning-dependent expression was specific to dorsomedial and ventromedial regions of caudate-putamen
(dmCPu, vmCPu). Only rats in the nicotine-CS condition, when challenged with nicotine, had higher c-Fos expression in the dmCPu and
vmCPu. These results suggest that medial areas of CPu involved in excitatory conditioning with an appetitive nicotine CS.
Neuropsychopharmacology (2012) 37, 876–884; doi:10.1038/npp.2011.263; published online 2 November 2011
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INTRODUCTION
Consumption of tobacco products is a leading cause of
preventable deaths both globally and in the United States.
Although rates of tobacco consumption are more prevalent
in the developing countries (70% of all tobacco users),
developed countries such as the United States suffer
considerable financial ($193 billion a year in health care
expenditures and lost productivity) and personal (443 000
people per year) loss (CDC, 2008). Chronic tobacco use is a
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debilitating habit in which a small fraction are able to quit
without intervention and others are in need of pharmacological and/or cognitive-behavioral therapies to increase
chances of long-term abstinence from tobacco.
Preclinical animal research in this area has focused
heavily on understanding the acute and repeated behavioral
and neurobiological effects of nicotine (Azizian et al, 2009;
Balfour, 2009; Barik and Wonnacott, 2009). A subset of this
research has focused on Pavlovian conditioning processes
where nicotine serves as an unconditioned stimulus (US).
This research has led to a better understanding of nicotine
dependence, and the translation of this work could improve
current treatment approaches such as cue-exposure therapy
(Conklin and Tiffany, 2002). Nicotine also has conditionedstimulus (CS) effect that may contribute to the persistence
of the smoking habit (Bevins and Murray, 2011; Bevins and
Palmatier, 2004). These interoceptive-stimulus effects of
nicotine serving as a CS have not been as well studied. As a
CS, the perceptible interoceptive effects of nicotine enter
into learned association with other appetitive stimuli or USs
that co-occur in the environment (eg, peer interaction/
acceptance, alcohol, food, work breaks). These acquired
appetitive properties of nicotine may evoke conditioned

c-Fos activation by nicotine conditioned stimulus
S Charntikov et al

877

response (CR) that contributes to the tenacity of the
addiction (Alessi et al, 2002; Bevins and Murray, 2011).
Animal studies have been especially useful in examining
nicotine in its role as a CS (Besheer et al, 2004; Murray and
Bevins, 2011; Struthers et al, 2009). In this animal model,
rats received nicotine (the CS) paired with intermittent
access to sucrose (the US); on intermixed saline days
sucrose is not available. Across sessions, differential goaltracking (anticipatory approach to location of the US;
Farwell and Ayres, 1979) develops in response to the
nicotine CS (Besheer et al, 2004; Murray and Bevins, 2007a;
Palmatier et al, 2005). Behaviorally, this conditioning
follows many of the postulates of Pavlovian conditioning
and could possibly simulate learning processes in human
smokers (Murray and Bevins, 2011; Murray et al, 2009).
Previous studies with this model have focused on the
behavioral or neuropharmacological mechanisms involving
the nicotine CS. However, to date there are no studies
focused on elucidating the neural substrates involved in the
expression of CR evoked by the nicotine CS. One technique
that is widely used to assess neuronal activity is immunostaining for the immediate early gene c-Fos (Curran and
Morgan, 1995; Kovács, 1998). The purpose of the present
experiment was to use neurohistochemical analysis of
rapidly developing c-Fos protein to elucidate the potential
neurobiological loci involved in the processing of nicotine
as an interoceptive CS.

MATERIALS AND METHODS
Animals
Subjects used were 72 male Sprague-Dawley rats purchased
from Harlan as young adults (275–290g; Indianapolis, IN,
USA). Rats were housed individually in clear polycarbonate
cages (48.3  26.7  20.3 cm) lined with wood shavings.
The temperature- and humidity-controlled colony room
was kept on a 12-h light/dark schedule. All experimental
manipulations were conducted during the light cycle. Water
access was freely available in the home cage and access to
chow (Harlan Teklad Rodent Diet; Harlan, KY, USA) was
restricted to maintain rats at 85% of their free-feeding body
weight. This 85% target weight was increased by 2 g
after 4 weeks into the study. Protocols were approved by
the University of Nebraska–Lincoln Animal Care and Use
Committee, and followed the ‘Guide for the Care and Use of
Laboratory Animals’ (Institute of Laboratory Animal
Resources (U.S.), 1996).

Apparatus
Behavioral testing was conducted in commercially available
chambers (ENV-008CT; Med Associates; St Albans, VT,
USA) measuring 30.5  24.1  21.0 cm (l  w  h) enclosed
in a sound and light attenuating cubicle equipped with an
exhaust fan. Each conditioning chamber had aluminum
sidewalls, metal rod floors with polycarbonate front, back,
and ceiling. A recessed receptacle (5.2  5.2  3.8 cm;
l  w  d) was centered on one of the sidewalls. A dipper
arm, when raised, provided access to 0.1 ml of 26% (w/v)
sucrose solution in the receptacle. Access to the dipper was
monitored by an infrared beam mounted 1.2 cm into the

receptacle and 3 cm above the chamber floor. A second
infrared beam that monitored general chamber activity was
located 4 cm above the floor and 14.5 cm from the sidewallcontaining receptacle. Beam breaks for dipper entries and
chamber crosses were monitored using Med Associates
interface and software (Med-PC for Windows, version IV;
St Albans, VT, USA).

Drugs
()-Nicotine hydrogen tartrate and sodium pentobarbital
(Sigma; St Louis, MO, USA) were dissolved in 0.9% saline.
Nicotine pH was adjusted to 7.0±0.2 with a dilute NaOH
solution. Nicotine dose (reported as base) and the 5-min
injection-to-placement interval were selected on the basis
of previous research (Murray and Bevins, 2007a, b).

Behavioral Procedures
Training. Rats were handled for a minimum of 2 min
on each of 3 consecutive days before the start of the
experiment. Rats were treated with 0.4 mg/kg nicotine (SC)
for 3 consecutive days before training to attenuate initial
locomotor-suppressant effects of nicotine (Besheer et al,
2004; Bevins et al, 2001). For each 32 daily training sessions,
all rats were injected (SC) with either nicotine (0.4 mg/kg) or
saline 5 min before placement in the conditioning chamber
for a 20-min session. Rats were randomly assigned to one of
three learning conditions: nicotine CS, chamber CS, and CS
alone (n ¼ 23–24 per condition). Rats in each condition
received a unique pseudorandom order of 16 nicotine and
16 saline sessions with the condition that no more than two
of the same session type (nicotine vs saline) occurred in
a row. In the nicotine-CS condition, nicotine was paired
with intermittent access to sucrose. Access to sucrose was
initiated between 124 and 152 s from the start of the session
with four possible times randomized throughout the training
phase. There were 36 separate 4-sec deliveries of sucrose per
nicotine session. Time between sucrose deliveries ranged
from 4 to 80 s (mean ¼ 25 s) and was randomized for each
session. For intermixed saline sessions, sucrose was withheld. The chamber-CS condition differed from nicotine-CS
condition only in that nicotine and saline were each pseudorandomly paired 50% of the time with sucrose. That is, half
of the saline sessions throughout training phase had 36
intermittent sucrose deliveries, whereas the remaining half
was without sucrose; the same was true for nicotine sessions.
The CS-alone condition differed from nicotine-CS condition only in that neither nicotine nor saline included
sucrose deliveries (ie, no access to sucrose throughout
experiment). Because our standardized testing session for
assessing stimulus control without an influence of sucrose
delivery is significantly shorter (ie, 4 min) than a training
session (ie, 20 min), this change of protocol on the final test
day could serve as a stressor contributing to the undesirable
non-specific c-Fos expression (Cullinan et al, 1995; Senba
and Ueyama, 1997). In order to minimize this possibility,
four mock-test sessions (two nicotine and two saline) were
interspersed within the training schedule to familiarize rats
with this testing protocol. All rats experienced either
nicotine or saline mock test following days 8, 12, 20, and
24 of training.
Neuropsychopharmacology
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Testing. On a final test day, half of the rats from each
condition (nicotine-CS, chamber-CS, CS-alone) were
injected SC with nicotine 5 min before the start of the
session; the remaining rats were injected with saline (3  2
design; 6 total groups; n ¼ 11–12 per group). For that test
session, rats were placed in the conditioning chambers for
4 min. Dipper entries and chamber crosses were recorded,
but sucrose was withheld.

c-Fos Immunohistochemistry
All rats were anesthetized and transcardially perfused
(0.9%. saline, 4% paraformaldehyde) 90 min after the final
test injection (detailed in Supplementary Materials and
Methods). Brains were rapidly removed and processed for
the c-Fos immunoreactivity as previously described by Zhao
and Li (2010) and detailed in Supplementary Methods.

Fos-Immunoreactive (Fos-I) Cell Counting
Two digital images (  10 magnification; 340 mm2) from
each area of interest were taken bilaterally from anatomically matched sections using an Olympus CX41RF
microscope (Japan) fitted with digital camera (Infinity lite,
Canada). Positively labeled nuclei (thresholded against
background) were identified and automatically counted
using NIH ImageJ software (Abramoff et al, 2004).
The number of Fos-I cells was averaged between the two
bilateral images from any given brain region and used
as a unit of measurement for statistical analyses (Shram
et al, 2007). Nuclei selected for the assessment (Figure 1)
represented brain regions implicated in the rewarding
and/or incentive motivational effects of drugs of abuse
( + 1.60 and 5.80 from bregma; eg, caudate-putamen
(dmCPu, dlCPu, vmCPu, vlCPu), nucleus accumbens
(AcbC, AcbSh), ventral pallidum (VP), ventral tegmental
area (VTA), substantia nigra (SNR)) (Pagliusi et al, 1996;
Robinson and Berridge, 2003; Smith et al, 2009), learning
and memory (2.80 from bregma; eg, hippocampus (CA1,
CA2, CA3, DG), amygdala (CeM, BLA, MeAD)) (Everitt and
Wolf, 2002; Squire, 1992), and executive and cognitive
functions (3.7 and 1.6 from bregma; eg, prelimbic cortex
(PrL), orbitofrontal cortex (OFC), anterior cingulate cortex
(Cg2)) (Balleine and Dickinson, 1998; Coutureau and
Killcross, 2003; Dalley et al, 2004; Killcross and Coutureau,
2003; Robbins, 2005).

Statistical Analyses
Statistical analyses were performed using the freely available
statistical package R (http://www.r-project.org). An omnibus analysis of variance (ANOVA) preceded all planned
comparisons. Higher-order interactions (detailed in the
Supplementary Materials and Methods) were further
analyzed by two-way ANOVAs and followed, if necessary,
by Tukey’s HSD post-hoc tests (po0.05). Although every
effort was taken to minimize variation between different
batches of immunohistochemical assays, subtle variation
is often expected (Rhodes et al, 2005). Thus to examine the
effect of training on Fos-I expression, a 3  2 (condition 
drug) randomized block design between-subject ANOVA
was performed with batch, containing equal number of
Neuropsychopharmacology

Figure 1 Schematic representation (adapted from Paxinos and Watson,
2007) of areas sampled for c-Fos immunoreactivity assessment. All areas
were located within anatomical levels represented on four coronal sections
( + 3.7, + 1.6, 2.80, 5.80). Black squares corresponding to adjacent
numbers represent approximate locations where digital images
were acquired from: (1) prelimbic cortex (PrL); (2) orbitofrontal cortex
(OFC); (3) Cg2 area of anterior cingulate cortex; (4) dorsomedial
caudate-putamen (dmCPu); (5) dorsolateral caudate-putamen (dlCPu);
(6) ventromedial caudate-putamen (vmCPu); (7) ventrolateral caudateputamen (vlCPu); (8) nucleus accumbens core (AcbC); (9) nucleus
accumbens shell (AcbSh); (10) ventral pallidum (VP); (11) CA1 area of
hippocampus; (12) CA2 area of hippocampus; (13) CA3 area of
hippocampus; (14) dentate gyrus (DG); (15) centromedial amygdaloid
nucleus (CeM); (16) basolateral amygdaloid nucleus (BLA); (17) medial
amygdaloid nucleus (MeAD); (18) ventral tegmental area (VTA);
(19) substantia nigra (SNR).

representatives from each group, as a blocking factor. Data
from two rats were excluded from all analyses because of an
injection error on the final test day.

RESULTS
Training
An omnibus ANOVA revealed that there were significant
main effects of training condition (ie, nicotine-CS,
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chamber-CS, CS-alone; F(2, 2142) ¼ 772.61, po0.0001),
drug (nicotine vs saline; F(1, 2142) ¼ 330.85, po0.0001),
and their interaction over time (condition  drug  session;
F(30, 2142) ¼ 5.87, po0.0001). Overall, responding on
nicotine sessions was significantly higher than on saline
sessions in the nicotine-CS and chamber-CS conditions, but
not in the CS-alone condition (condition  drug interaction;
F(2, 2077) ¼ 175.94, po0.0001; Tukey HSD tests; see
Figure 2). In the nicotine-CS condition, conditioned
responding evoked by the nicotine CS was higher than
saline from session 5 through 16 (separate two-way

ANOVA; drug  session interaction; F(15, 724) ¼ 18.15,
po0.0001; Tukey HSD tests; Figure 2a). There was weak
differential responding across session type in the chamberCS condition; post-hoc comparisons revealed greater
responding in the nicotine than saline session only on
session 14 (separate two-way ANOVA; drug  session
interaction; F(15, 675) ¼ 4.43, po0.0001; Tukey HSD tests;
Figure 2b).

Testing
In the 4-min test, there was a main effect of condition
(F(2, 63) ¼ 46.59, po0.0001) and a main effect of test drug
(F(1, 63) ¼ 48.47, po0.0001) on rate of dipper entries.
Further, the condition  drug interaction was significant
on this test; F(2, 63) ¼ 11.78, po0.0001. Unlike rats that
underwent CS-alone training, rats in the nicotine-CS and
chamber-CS conditions had significantly higher dipper
entries when challenged with nicotine relative to saline
(Tukey HSD tests; Figure 3). Among nicotine-challenged
rats, dipper entries in the nicotine-CS and chamber-CS
condition did not differ from each other, but were
significantly higher than CS-alone rats (Tukey HSD tests).
Among rats pretreated with saline, only rats in the chamberCS condition differed significantly from CS-alone rats
(Tukey HSD tests). Notably, there was no main effect of
training condition or test drug, nor was there an interaction
for general chamber activity (F(2, 63) ¼ 0.61, p40.05; data
not shown).

Fos Immunoreactivity
Table 1 summarizes main effects (condition, drug) and
interactions with a number of positively identified Fos-I
cells as the dependent measure. On the test day, rats in
nicotine-CS condition had significantly higher expression of
Fos-I cells in the AcbC and vmCPu when compared with the
CS-alone condition (for all means (±SEM) see Table 2).
In concordance with previous reports, nicotine challenge on

Figure 2 Dipper entry rates (±SEM) from rats in (a) nicotine-CS, (b)
chamber-CS, and (c) CS-alone conditions of a training phase. *Significant
from saline session(s) (*Po0.05, ***Po0.001).

Figure 3 Dipper entry rates (±SEM) on the final 4-min test.
**,***Significant from saline treatment. aSignificantly different from
b
nicotine-treated CS-alone control (**Po0.01, ***Po0.001).

Neuropsychopharmacology
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Table 1 ANOVA (Main Effects and Interaction) Results of c-Fos
Expression by Regions Tested
Condition ME
F (2,53)

Condition  Drug

Drug ME

P

F (1,53)

P

F (2,53)

P

Prefrontal Cortex
PRL

0.09

0.97

19.41

***

0.60

0.55

ORF

0.91

0.40

13.60

***

0.54

0.58

CG2

1.48

0.23

27.94

***

1.27

0.29

dmCPu

2.28

0.11

63.13

***

3.81

*

dlCPu

1.42

0.25

6.11

*

4.09

*

vmCPu

4.07

*

49.46

***

3.51

*

vlCPu

0.86

0.42

6.02

*

2.08

0.13

ACBc

3.76

*

48.17

***

0.92

0.4

ACBsh

1.02

0.36

35.02

***

1.98

0.14

CA1

2.13

0.12

10.00

**

0.16

0.85

CA2

1.54

0.22

1.57

0.21

0.99

0.37

CA3

1.83

0.17

0.89

0.34

0.98

0.38

DG

2.44

0.09

0.02

0.88

0.85

0.43

CEM

0.32

0.72

11.87

**

0.09

0.90

BLA

1.10

0.33

27.25

***

1.04

0.35

MEAD

0.09

0.90

9.76

**

2.65

0.08

VP

2.29

0.11

27.76

***

1.09

0.34

VTA

2.23

0.11

10.45

**

1.29

0.28

SNR

0.01

0.98

1.12

0.29

2.79

0.07

Striatum

Hippocampus

Amygdala

Other areas

*Po0.05, **Po0.01, ***Po0.001.

the test day significantly increased c-Fos expression in a
majority of the areas assessed (main effect of drug; PrL,
OFC, Cg2, dmCPu, dlCPu, vmCPu, vlCPu, AcbC, AcbSh,
CA1, CeM, BLA, MeaD, VP, VTA). Among rats challenged
with nicotine, rats in the nicotine-CS condition (ie, those
expressing a nicotine-evoked CR) had significantly higher
c-Fos expression in dmCPu and vmCPu when compared
with chamber-CS and CS-alone conditions (condition 
drug interaction; Tukey HSD tests; Figure 4). Rats
challenged with nicotine in the nicotine-CS condition had
significantly higher c-Fos expression in the dlCPu when
compared with saline (condition  drug interaction; Tukey
HSD tests; Figure 4). Figure 5 illustrates representative
sample of c-Fos immunoreactivity in the dmCPu.

DISCUSSION
This is the first study to identify neurobiological loci
(dmCPu, vmCPu) involved in the expression of CR evoked
by the interoceptive CS effects of nicotine. The magnitude of
Neuropsychopharmacology

expression of rapidly developing c-Fos protein oncogene
was used as a measure of neuronal activity within brain
regions carefully selected for their possible involvement in
excitatory conditioning processes involving the nicotine
stimulus. Specificity of neuronal activity for this conditioning was achieved by comparing the nicotine-CS condition to
two control conditions. In the first control condition
(chamber-CS), exposure to nicotine and sucrose reward
was identical to the nicotine-CS condition except that
nicotine was not reliably paired with sucrose. That is, across
training, half of the nicotine sessions were paired with the
sucrose US and half of the saline sessions were paired with
sucrose. Thus, the conditioning chamber cues, and not the
presence or absence of nicotine, were the most reliable
stimuli associated with sucrose (50% of all sessions with
chamber stimuli reinforced). In the second control condition (CS-alone), all rats had identical exposure to nicotine,
when compared with nicotine-CS and chamber-CS conditions, but sucrose was never available. Therefore, this
condition served to establish levels of neuronal activation
following repeated nicotine-alone treatment in a pattern like
the nicotine-CS condition.
With these controls in mind, nicotine-induced c-Fos
expression in the medial caudate-putamen (dmCPu,
vmCPu) was dependent on the learning history. Rats in
the nicotine-CS condition, when challenged with nicotine
on the test day, had significantly higher c-Fos expression in
the medial regions of caudate-putamen (dmCPu, vmCPu) in
comparison with controls. In addition, nicotine CS was the
only condition that exhibited differential (nicotine vs saline)
c-Fos expression in the dlCPu. Previous investigations into
the functioning of dorsal CPu may provide a better
understanding of a role of this area as it relates to our
experimental conditions. For example, Schultz (1998, 2006)
has shown that dopaminergic neurons within the caudateputamen can be activated by just presenting a stimulus (ie,
CS) that had been reliably paired with reward. Furthermore,
it appears that the dorsal CPu and not NAc mediates
cue-activated drug-seeking in rats with chronic cocaine
self-administration history (Vanderschuren et al, 2005a;
Vanderschuren and Everitt, 2005b). During cocaine-seeking
behavior contingent upon presentation of a light stimuli
previously paired with cocaine (no cocaine available),
dopamine levels are elevated in the dorsal CPu, but not in
the AcbC or AcbSh (Ito et al, 2000, 2002; Neisewander et al,
1996). Moreover, dopamine receptor blockade in the dorsal
CPu, but not in the AcbC, dose-dependently attenuates
cocaine-seeking (Vanderschuren et al, 2005a). These findings lend support to the hypothesis that as drug use
progresses from the initial stages to the dependence state,
the behavior depends less on NAc and progressively more
on dorsal CPu. Because this transition could be indicative of
dorsal CPu’s involvement in habitual stimulus–response
processes (Berke and Hyman, 2000; Everitt and Robbins,
2005; Tiffany, 1990; Vanderschuren et al, 2005a), finding
of the present study may in part reflect effects of habitual
learning with nicotine as an appetitive (associated with
reward) CS.
Although no previous studies have investigated anatomical regions involved in learning with nicotine as the
appetitive CS, chronic nicotine administration has been
shown to induce c-Fos immunoreactivity in a number of
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Table 2 Number (±SEM) of c-Fos Positively Labeled Nuclei by Groups and Regions Tested
0.4 mg/kg Nicotine

Vehicle

nicotine-CS

chamber-CS

CS-alone

nicotine-CS

chamber-CS

CS-alone

39.63±6.39
106.56±15.92
39.00±6.45

35.67±8.62
91.81±18.41
31.21±8.51

36.69±6.42
100.54±9.20
25.83±3.67

19.58±3.21
78.38±12.60
16.00±2.84

23.41±4.46
69.25±14.59
12.59±3.97

23.91±3.24
57.09±14.02
15.77±3.04

39.96±6.32
9.50±2.44

26.54±5.54
5.48±1.54

25.96±3.61
3.94±0.86

10.57±2.37
5.18±2.46

45.63±6.68
9.56±2.32

31.00±5.94
6.90±2.15

29.81±5.72
4.77±1.07

8.83±1.17
2.10±0.54
17.31±2.31

41.63±6.12
23.31±4.19

38.48±6.80
18.19±4.64

30.02±4.78
17.38±2.86

CA3

8.31±1.53
8.77±1.83
9.08±1.93

7.27±1.70
7.58±1.79
6.71±1.25

DG

17.70±5.02

Prefrontal Cortex
PrL
OFC
Cg2
Striatum
dmCPu
dlCPu
vmCPu

17.59±4.16
4.89±2.46

9.77±1.46

20.55±3.94
9.84±1.76

4.11±1.05
16.68±2.94
10.20±1.78

9.04±1.66
7.25±1.47
6.35±1.48

5.35±1.10
8.15±1.89
7.21±1.07

4.82±1.56
5.23±1.78
5.23±1.55

6.98±2.07
7.09±2.52

15.27±3.03

12.68±3.41

12.20±3.50

8.07±1.96

11.26±3.41

BLA

12.81±4.03
10.44±2.18

11.46±1.45
13.15±2.48

11.04±3.09
9.13±2.13

7.08±1.49
5.10±1.06

5.11±0.69
4.70±0.59

6.39±1.49
4.70±0.78

MeAD

14.94±2.31

15.29±2.41

12.33±1.51

9.79±1.97

10.20±1.47

12.30±2.10

17.05±2.50
26.02±3.55
9.69±1.95

18.96±4.94
22.04±3.48
6.77±1.46

12.15±1.27
18.96±2.77
5.50±1.39

8.63±2.52
18.17±2.45
3.33±1.18

7.11±1.37
10.91±1.97
6.64±3.00

6.05±0.96
16.48±3.61
7.36±3.11

vlCPu
AcbC
AcbSh

3.19±1.08
21.44±3.33

9.00±2.22
2.93±0.64
14.25±3.07

Hippocampus
CA1
CA2

7.02±1.63

Amygdala
CeM

Other areas
VP
VTA
SNR

Figure 4

Means (±SEM) of positively labeled c-Fos nuclei. *Significant difference indicated by dashed brackets (Po0.05).

cortical and mesolimbic areas (Marttila et al, 2006; Pagliusi
et al, 1996; Salminen et al, 1999). Our findings corroborate
these previous reports. Receiving a nicotine challenge on

the test day induced c-Fos immunoreactivity in 15 out of
19 areas examined. The exceptions were CA2, CA3, and DG
of the hippocampus and SNR. These areas of hippocampus
Neuropsychopharmacology
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Figure 5 Photomicrographs (  10 magnification) of c-Fos immunoreactivity in the dmCPu of rats from all groups challenged by nicotine or saline on a
final test day. Black arrows are indicating positively labeled nuclei. Scale bar ¼ 100 mm.

and SNR are not typically assessed for the c-Fos activity
associated with nicotine treatments, however, at least one
study (Pagliusi et al, 1996) also found little to no (eg, o3
positive cells in the case of DG) immunoreactive c-Fos
nuclei following chronic nicotine self-administration in
these areas.
The mesolimbic system is central to reward- and drugdependence processes. The mesolimbic system also is
critically involved in mediating direct reinforcing effects
of nicotine (Corrigall, 1999; Corrigall and Coen, 1989;
Corrigall et al, 1992, 1994; Di Chiara, 2000). However, our
results indicate that c-Fos expression in both VTA
(mesolimbic dopamine production) and ACBc (recipient
of dopamine signal from the VTA) was not affected by the
appetitive learning history. This possible neuroanatomical
difference between loci of the primary appetitive or
reinforcing effects and the acquired appetitive properties
is a potentially important dissociation that deserves future
empirical attention.
The behavioral pattern for the three learning conditions
in this experiment was somewhat predictable on the basis of
the previous investigations into nicotine as an interoceptive
CS. As noted earlier, the interoceptive-stimulus effects of
nicotine readily acquired the ability to evoke a food-seeking
CR when nicotine was consistently paired with sucrose (ie,
nicotine-CS condition) (Bevins, 2009). In comparison, rats
that were trained with nicotine alone (ie, no sucrose
throughout entire experiment; CS-alone condition) had
very low dipper entry rates on either session type (nicotine
or saline) compared with nicotine-CS or chamber-CS
conditions. Thus, mere exposure to nicotine and its
psychomotor effects was not sufficient to significantly
increase dipper entries. As detailed earlier, the chamber
cues serve as the best predictor for sucrose access in the
chamber-CS condition. As the chamber was the most
reliable stimulus associated with sucrose, the chamber
stimuli evoked goal-tracking on nicotine and saline
sessions. By the end of training, goal-tracking in the
Neuropsychopharmacology

chamber-CS condition on nicotine sessions was higher
when compared with saline sessions. Although significance
was only observed at one time point (session 14), this
difference seemed to be stabilizing towards the end of
training; the difference continued on the tests session.
Although the increased responding in the later nicotine
sessions for the rats in the chamber-CS condition was not
anticipated, there are possible explanations for this effect.
One possibility is that nicotine enhanced the salience of the
chamber-associated stimuli. This explanation is based on
work by Olausson, Jentsch, and Taylor (2004). In that study,
they found that nicotine enhanced responding for the
compound CS (light + tone) previously associated with
water (see also Caggiula et al, 2001; Chaudhri et al, 2006).
Accordingly, perhaps the acquired appetitive properties
of the chamber stimuli, evidenced by the goal-tracking in
the saline state, were enhanced by the nicotine. Such
enhancement would augment the CR evoked by the
chamber CS. Additional support for this account is found
in the nicotine self-administration literature. For example,
responding for a light + tone compound stimulus that had
been previously paired with sucrose as a means to increase
its mildly rewarding effect, was enhanced by either
contingent or non-contingent nicotine infusions (IV) when
compared with saline controls (Chaudhri et al, 2006).
Another possibility is that under this intermittent
schedule where nicotine is partially paired with sucrose,
the nicotine stimulus slowly acquires some control over
goal-trackingFwith the other features (elements) of the
chamber still controlling a majority of the responding, given
the richer reinforcement density. Albeit possible, we have
published data that suggests that this possibility is unlikely
(Bevins et al, 2007; Murray et al, 2011). In these studies, the
nicotine stimulus, along with all the chamber stimuli, was
paired with sucrose on every session. There were no saline
sessions, thus 100% of the nicotine + chamber sessions were
reinforced. This schedule of reinforcement is much richer
than the present work (50% of nicotine sessions, with 50%
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on no-nicotine sessions also being reinforced). According to
this account, the nicotine stimulus in the 100% scenario
should control some of the goal-tracking. To test this
possibility, rats were treated with saline rather than nicotine
for the first time. Removal of the nicotine stimulus did not
significantly disrupt goal-tracking behavior (Bevins et al,
2007; Murray et al, 2011), suggesting that nicotine in these
studies was not a sufficiently salient stimulus element to
acquire control of behavior when the external chamber cues
were as good of a predictor. In the present study, these
chamber cues were even a better predictor than nicotine.
Regardless, even if nicotine was an element with some
control over the goal-tracking behavior, the magnitude of
nicotine’s control was not sufficient to drive activation of
medial caudate-putamen.
Finally, one might suggest that the locomotor stimulant
effects of nicotine contributed to the increase in goaltracking on nicotine sessions for the chamber-CS condition.
This possibility also seems unlikely. First, there was no
difference in general chamber activity among the groups
tested with either nicotine or saline on the final test day; ie,
no stimulant effect of nicotine detected in that brief 4-min
test. Second, nicotine administration did not enhance
dipper entries (goal-tracking) during the training or testing
phase in the CS-alone condition. This lack of effect suggests
that there needs to be some learning regarding access to
sucrose to occur for nicotine to enhance the goal-tracking
response (see previous paragraph).
Although nicotine enhanced goal-tracking behavior evoked
by chamber stimuli in the chamber-CS condition, this
difference was not manifested in differential expression of
c-Fos in the areas examined in this study. Perhaps we were
not able to find a neurobiological substrate for this effect
because of the limited sensitivity of the immunohistochemical
assay, limited number of regions tested, or because this effect
was also a minor contributing factor in the nicotine-CS
condition. Nevertheless, in light of these findings, chamberCS training protocol provides new evidence for the nicotine
enhancement effect of the acquired incentive salience of other
stimuli (for recent review see Bevins and Caggiula, 2009) and
could possibly serve as a new model to further elucidate this
phenomenon.
In sum, nicotine is capable of serving as a CS for an
appetitive reward, such as sucrose. This effect was
evidenced here by nicotine acquiring differential control
of a goal-tracking CR in the nicotine-CS condition. The
present research suggests that this appetitive conditioning
involves dorsomedial and ventromedial regions of CPu. Our
findings present a first account of specific regional neural
activation by nicotine as a CS. Understanding neurobiological mechanisms underlying nicotine’s function as an
appetitive CS could provide a foundation for more
comprehensive paradigms deployed to elucidate what seem
to be complex and multifaceted mechanisms underlying
nicotine dependence.
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